Skip to content

PET study of brain tau deposition in traumatic brain injury using [11C]PBB3

PET study of brain tau deposition in traumatic brain injury using [11C]PBB3 - PET study of brain tau deposition in traumatic brain injury using [11C]PBB3

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013517
Enrollment
32
Registered
2014-04-01
Start date
2014-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer, Traumatic brain injury (TBI)

Interventions

PET/MRI/neuropsychological batteries/neurological examinations PET/MRI/neuropsychological batteries/neurological examinations

Sponsors

National Institute of Radiological Sciences
Lead Sponsor
Keio University School of Medicine
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: I. Patients 20 y.o.<=Age<=65 y.o. patients suffering from TBI whose mechanism of injury was specified. II.Healthy volunteers 20 y.o.<=Age<=65 y.o., normal subjects

Exclusion criteria

Exclusion criteria: I. Patients 1. Subjects without ability to make informed consent 2. Subjects with any psychiatric disorder not due to TBI 3. Subjects with any organic brain disorder not due to TBI 4. Subjects with severe physical complication 5. Subjects with severe claustrophobia 6. Pregnant women 7. Subjects with tattoo 8. Subjects with metallic medical device in the body 9. Subjects who was considered to be inappropriate to participate in the study II. Healthy volunteers 1. Subjects without ability to make informed consent 2. Subjects with any psychiatric disorder 3. Subjects with any organic brain disorder 4. Subjects with severe physical complication 5. Subjects with severe claustrophobia 6. Subjects who has participated in other study in recent 6 months. 7. Pregnant women 8. Subjects with tattoo 9. Subjects with metallic medical device in the body 10. Subjects who was considered to be inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Distribution volume and binding potential measured by positron emission tomography with [11C]PBB3

Secondary

MeasureTime frame
Difference of spatial distribution of [11C]PBB3 and [11C]PIB Correlations between tau deposition and various clinical scales

Countries

Japan

Contacts

Public ContactKeisuke Takahata

National Institute of Radiological Sciences Molecular Imaging Center

takahata.keisuke@qst.go.jp81432063025

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026